Workflow
基石药业-B(02616.HK)授出合共480万份购股权

Core Viewpoint - 基石药业-B (02616.HK) announced the granting of stock options and restricted share units to employees as part of its employee stock ownership plan and restricted share award plan following its initial public offering [1] Group 1 - The company granted a total of 4.8 million stock options to 5 option grantees, with an exercise price of HKD 10.00 per share [1] - Additionally, the company awarded a total of 1.93 million restricted share units to 5 restricted share unit grantees [1]